NEW ZEALAND: Fight against Botrytis eyes February listing
Botry-Zen, the company that owns the rights to a biological control preventing botrytis in grapevines, will attain a listing on the New Zealand stock exchange in February, it said. The company has already had to return around NZ$115m in over-subscriptions for the NZ$5m share issue. Botry-Zen's 166m shares were issued at 10c each but have been trading in the mid-20c range, until rising to their current level of 40c two weeks ago.
Get full access to all content, just $1 for 30 days
A Message From The Editor
just-drinks gives you the widest beverage market coverage.
Paid just-drinks members have unlimited access to all our exclusive content - including 14 years of archives.
I am so confident you will love complete access to our content that today I can offer you 30 days access for $1.
It’s our best ever membership offer – just for you.
Olly Wehring, editor of just-drinks
- Analysis - SABMiller's Australian issues continue
- PepsiCo to consider more re-franchising - CEO
- Focus - SABMiller's Q1 Performance by Region
- Analysis - Coca-Cola fails confidence test
- Brazil could have been worse - Coca-Cola Co CEO
- Diageo's Captain Morgan Facebook ad banned
- Sales, profits fall at Moet Hennessy in H1
- Alcohol retailer group appoints new chairman
- Champagne Nicolas Feuillatte appoints new CEO
- Beam Suntory's Laphroaig Select